IL22 and myeloid sarcoma: Herein IL-6, IL-17A and IL-22, all of which contribute to T-cell subset regulation and MS pathology, were differentially methylated over time in CD4+ T cells (Fig. 5), all of which contribute to T cell subset regulation and MS pathology.